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See related letter by De Pascale and Quraishi, http://ccforum.com/content/18/4/449The problem of vitamin D deficiency during intensive
care requires a number of clarifications. Initially, it is es-
sential to focus on the fundamentals of vitamin D status
assessment. Total 25-hydroxyvitamin D (25OH-D) is
currently considered as the best indicator of vitamin D
status. Due to practical reasons (less knowledge needed,
higher throughput), immunoassays are generally pre-
ferred to measure serum 25OH-D levels. In the critical
care context, however, they may be biased due to matrix
effects [1]. During the acute phase of critical care, these
assays should then be abandoned in favor of liquid
chromatography-tandem mass spectrometry. Moreover,
standardization of vitamin D assays is crucial: such a
process is ongoing worldwide but, to date, is still incom-
plete. It is important to note that both points are rarely
considered in the published studies related to vitamin D
in critically ill patients: the data may thus be interpreted
with caution.
The bioavailable and free fraction of 25OH-D are
attractive complementary markers of vitamin D status;
however, progress is needed before establishing their evi-
dence [2]. We need an accurate assay rather than formulas
to measure free and bioavailable concentrations. We also
need to determine normal or optimal ranges and to in-
vestigate their clinical impact. In the future, it seems im-
portant to consider these analytical prerequisites when
studying vitamin D in critically ill patients. Meanwhile,
these patients should benefit from the potential benefi-
cial effects of vitamin D. Cholecalciferol is, in fact, a
cheap medication with a wide therapeutic window. We
believe that the critically ill should be supplemented
with vitamin D as they are clearly at risk of deficiency.
Meanwhile, for specific protocols, intensivists should at
least follow the Endocrine Society guidelines [3,4].* Correspondence: afrousseau@chu.ulg.ac.be
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